Characteristics of HIV-1 Natural Drug Resistance-Associated Mutations in Former Paid Blood Donors in Henan Province, China

Greater Suppression of Nevirapine Resistance With 21- vs 7-Day Antiretroviral Regimens After Intrapartum Single-Dose Nevirapine for Prevention of Mother-to-Child Transmission of HIV

(2013) D. K. McMahon et al.   CLINICAL INFECTIOUS DISEASES

Incidence and Associated Factors of HIV Drug Resistance in Chinese HIV-Infected Patients Receiving Antiretroviral Treatment

(2013) Hui Xing et al.   PLoS One

Approaches for Identification of HIV-1 Entry Inhibitors Targeting gp41 Pocket

(2013) Fei Yu et al.   Viruses-Basel

Rilpivirine resistance mutations in HIV patients failing non-nucleoside reverse transcriptase inhibitor-based therapies

(2012) Lourdes Anta et al.   AIDS

Short Communication: Emerging Transmitted HIV Type 1 Drug Resistance Mutations Among Patients Prior to Start of First-Line Antiretroviral Therapy in Middle and Low Prevalence Sites in China

(2012) Xia Wang et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

Broad Phenotypic Cross-Resistance to Elvitegravir in HIV-Infected Patients Failing on Raltegravir-Containing Regimens

(2012) Carolina Garrido et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Assessment, Diagnosis, and Treatment of HIV-Associated Neurocognitive Disorder: A Consensus Report of the Mind Exchange Program

(2012) et al.   CLINICAL INFECTIOUS DISEASES

HIV-1 Subtype and Virological Response to Antiretroviral Therapy: A Confirmatory Analysis

(2012) David I. Dolling et al.   CLINICAL INFECTIOUS DISEASES

Past, Present, and Future of Entry Inhibitors as HIV Microbicides

(2012) Richard M. Gibson et al.   CURRENT HIV RESEARCH

HIV Types, Groups, Subtypes and Recombinant Forms: Errors in Replication, Selection Pressure and Quasispecies

(2012) Josef Eberle et al.   INTERVIROLOGY

Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis

(2012) Ravindra K Gupta et al.   LANCET

HIV Develops Indirect Cross-resistance to Combinatorial RNAi Targeting Two Distinct and Spatially Distant Sites

(2012) Priya S Shah et al.   MOLECULAR THERAPY

The structural biology of HIV-1: mechanistic and therapeutic insights

(2012) Alan Engelman et al.   NATURE REVIEWS MICROBIOLOGY

Different HCV Genotype Distributions of HIV-Infected Individuals in Henan and Guangxi, China

(2012) Di Tian et al.   PLoS One

The impact of quasispecies dynamics on the use of therapeutics

(2012) Celia Perales et al.   TRENDS IN MICROBIOLOGY

Standing Genetic Variation and the Evolution of Drug Resistance in HIV

(2012) Pleuni Simone Pennings   PLoS Computational Biology

The Prevalence of Drug Resistance Mutations Among Treatment-Naive HIV-Infected Individuals in Beijing, China

(2011) Jing-rong Ye et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

Incidence of HIV-1 Drug Resistance Among Antiretroviral Treatment–Naive Individuals Starting Modern Therapy Combinations

(2011) Viktor von Wyl et al.   CLINICAL INFECTIOUS DISEASES

Low-Frequency HIV-1 Drug Resistance Mutations and Risk of NNRTI-Based Antiretroviral Treatment Failure

(2011) Jonathan Z. Li   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study

(2011) Raph L Hamers et al.   LANCET INFECTIOUS DISEASES

Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study

(2011) Raph L Hamers et al.   LANCET INFECTIOUS DISEASES

The human immunodeficiency virus-1 genotype diversity and drug resistance mutations profile of volunteer blood donors from Chinese blood centers

(2011) Peibin Zeng et al.   TRANSFUSION

Genotypic and Phenotypic Cross-Drug Resistance of Harboring Drug-Resistant HIV Type 1 Subtype B′ Strains from Former Blood Donors in Central Chinese Provinces

(2010) Liying Ma et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

Characterization of the E138K Resistance Mutation in HIV-1 Reverse Transcriptase Conferring Susceptibility to Etravirine in B and Non-B HIV-1 Subtypes

(2010) Eugene L. Asahchop et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

HIV type-1 drug resistance in antiretroviral treatment-naive adults infected with non-B subtype virus in the United Kingdom

(2010) Daniella N Chilton et al.   ANTIVIRAL THERAPY

Increasing prevalence of transmitted drug resistance mutations and non-B subtype circulation in antiretroviral-naive chronically HIV-infected patients from 2001 to 2006/2007 in France

(2010) D. Descamps et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

HIV-Infected Former Plasma Donors in Rural Central China: From Infection to Survival Outcomes, 1985–2008

(2010) Zhihui Dou et al.   PLoS One

Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study

(2008) Nancy Crum-Cianflone et al.   AIDS

Minority Quasispecies of Drug‐Resistant HIV‐1 That Lead to Early Therapy Failure in Treatment‐Naive and ‐Adherent Patients

(2008) Karin J. Metzner et al.   CLINICAL INFECTIOUS DISEASES

Minority HIV-1 Drug Resistance Mutations Are Present in Antiretroviral Treatment–Naïve Populations and Associate with Reduced Treatment Efficacy

(2008) Jeffrey A Johnson et al.   PLOS MEDICINE